Left atrial appendage closure offers promising ischaemic outcomes in patients with atrial fibrillation who refuse to take ...

Left atrial appendage closure (LAAC) was well tolerated and may be considered as an alternative to oral anticoagulation (OAC) ...

The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk ...

Doctors are warning that a silent heart rhythm disorder, known as atrial fibrillation, is emerging as a major cause of repeat ...

Combining an antiplatelet with oral anticoagulants in stroke patients with AF and cardiovascular disease slightly lowers ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use ...

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and remains a significant contributor to morbidity and mortality worldwide. A central focus of current research is the left ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...